A recent study shows an 8-gene signature based on LMGs including RTN2, FYN, HEYL, FAM69A, FBXL5, HMGN2, LGALS4, STOX1 as a novel marker to predict colon cancer patients’ survival [8]. This evidence concerns the gene STOX1 and colonic neoplasm.